Inflammatory Bowel Disease and Risk of Colorectal Cancer: An Overview From Pathophysiology to Pharmacological Prevention.
Reads0
Chats0
TLDR
The authors in this paper summarized the current knowledge of IBD-CRC, focusing on the main mechanisms underlying its pathogenesis, and on the important role of immunomodulators and biologics used to treat IBD patients in interfering with the inflammatory process involved in carcinogenesis.Abstract:
Increased risk of colorectal cancer (CRC) in inflammatory bowel disease (IBD) patients has been attributed to long-standing chronic inflammation, with the contribution of genetic alterations and environmental factors such as the microbiota. Moreover, accumulating data indicate that IBD-associated CRC (IBD-CRC) may initiate and develop through a pathway of tumorigenesis distinct from that of sporadic CRC. This mini-review summarizes the current knowledge of IBD-CRC, focusing on the main mechanisms underlying its pathogenesis, and on the important role of immunomodulators and biologics used to treat IBD patients in interfering with the inflammatory process involved in carcinogenesis.read more
References
More filters
Journal ArticleDOI
Ulcerative colitis and colorectal cancer. A population-based study.
TL;DR: Close surveillance and perhaps even prophylactic proctocolectomy should be recommended for patients given a diagnosis of pancolitis, especially those who are less than 15 years of age at diagnosis.
Journal ArticleDOI
Targeting the IL-6/JAK/STAT3 signalling axis in cancer.
TL;DR: Treatments that target the IL-6/JAK/STAT3 pathway in patients with cancer are poised to provide therapeutic benefit by directly inhibiting tumour cell growth and by stimulating antitumour immunity.
Book ChapterDOI
The role of short-chain fatty acids in health and disease.
Jian Tan,Craig R. M. McKenzie,Maria Potamitis,Alison N. Thorburn,Charles R. Mackay,Laurence Macia +5 more
TL;DR: The role of SCFAs as a major player in maintenance of gut and immune homeostasis is highlighted, and their levels are regulated by diet are provided a new basis to explain the increased prevalence of inflammatory disease in Westernized countries.
Journal ArticleDOI
Mucosal flora in inflammatory bowel disease
Alexander Swidsinski,Axel Ladhoff,Annelie Pernthaler,Sonja Swidsinski,Vera Loening-Baucke,Marianne Ortner,Jutta Weber,Uwe Hoffmann,Stefan Schreiber,Manfred Dietel,Herbert Lochs +10 more
TL;DR: It is hypothesized that the healthy mucosa is capable of holding back fecal bacteria and that this function is profoundly disturbed in patients with IBD, suggesting that the changes in the mucosal flora in IBD are not secondary to inflammation, but a result of a specific host response.
Journal ArticleDOI
Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis
Matthew D. Rutter,Brian Saunders,Kay H. Wilkinson,Steve Rumbles,Gillian Schofield,Michael A. Kamm,Christopher S. Williams,Ashley B. Price,Ian C. Talbot,Alastair Forbes +9 more
TL;DR: In long-standing extensive ulcerative colitis, the severity of colonic inflammation is an important determinant of the risk of colorectal neoplasia and endoscopic and histological grading of inflammation could allow better risk stratification for surveillance programs.
Related Papers (5)
The Role of Proinflammatory Pathways in the Pathogenesis of Colitis-Associated Colorectal Cancer.
Chengxin Luo,Hu Zhang +1 more